Optimize your medicines and medical device development to get to the market safely and quickly, utilizing SGS Health Science's unique expertise, resources, and network. Contact us: healthscience@sgs.com ---- We are SGS – the world's leading testing, inspection, and certification company. We are recognized as the global benchmark for sustainability, quality, and integrity. Our 99,600 employees operate a network of 2,600 offices and laboratories, working together to enable a better, safer, and more interconnected world. --- Intellectual Property Statement: Except where expressly stated otherwise, all intellectual property rights, including copyright and trademarks, in any and all communications and materials in any form published by or on behalf of SGS are owned by SGS Société Générale de Surveillance SA, Switzerland. Link to statement on sgs.com: https://www.sgs.com/en/intellectual-property-statement
Externer Link zu SGS Health Science
Calling on pharma professionals! Your insights are crucial. Share your thoughts in our survey on whether healthy volunteers' feedback can improve the review process of clinical trial documents. ✍ Vote below and if you have 1 more minute to spare, please take the full survey. 👉 https://lnkd.in/gFQi8gxp #clinicalresearch
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
The ultimate goal is to minimize the use of patients for non-therapeutic dosages and quickly transition to the most effective treatments for them. 🔍 Ever wondered if using healthy volunteers in early oncology trials might be a game-changer? 👇 Answer in comments 👉 Watch the webinar recording to have Nick Praet explain the pro’s and con’s of involving healthy volunteers in early-phase oncology studies. https://lnkd.in/gihrjBZT #clinicalresearch #oncology #cancerresearch
💡Did you know? 🔬 Mycoplasma testing is a crucial element in the safety and quality of the pharmaceutical industry, but did you know that... 1️⃣ Mycoplasmas are bacteria without a cell wall: Unlike most bacteria, mycoplasmas do not have a cell wall, making them more difficult to detect and eliminate. 2️⃣ Mycoplasmas can contaminate cell cultures: Mycoplasmas pose a serious threat to laboratory cell cultures, leading to false results and compromising scientific research. 3️⃣ Mycoplasma testing is mandatory in many pharmaceutical regulations: Regulatory agencies worldwide, such as the FDA in the United States and the EMA in Europe, require mycoplasma testing to ensure the safety of pharmaceutical products. 💼 We lead the way in mycoplasma detection and elimination. As an international group, we enable you to benefit from mastery of all applicable regulations. Trust us for reliable mycoplasma testing that meets the strictest standards. 💡 Did you know? You can save posts for later! Just click the three dots (⋯) on the top right of the post and select "Save." #drugdevelopment #MycoplasmaTesting #VLG
As CDISC CORE beta testers, conformance rule developers and trusted partners, we're at the forefront of innovation, using the latest tools to enhance our clinical trial processes. Roman Radelicki shared his experiences with CORE and wowed CDISC's COSA Spotlight attendees with with his insightful presentation: 'CORE-Authoring and Running Your Own Rules'. 📽️ Watch the recording here: https://lnkd.in/ejDXx56q Need help getting started with CORE? Reach out to us at clinicalresearch@sgs.com. #clinicalresearch #CDISC
🏆 We’re honored with a prestigious CRO Leadership Award in five categories. Highlighting the 'Capabilities' category. This recognition underscores our commitment to providing top-tier services across the EU and US, including comprehensive offerings like CDMO bioanalysis and clinical development. Our innovative approach, such as SGS PACE, ensures our clients benefit from streamlined processes and advanced solutions. 💡 In particular, our functional service provider model for biometrics sets us apart, delivering unmatched expertise in areas like biostatistics, data management, and more. Learn more: https://lnkd.in/eYJ4u4kT A heartfelt thank you to all our clients for your trust and support! #healthscience #CROleadershipawards
Join our experts, Mahdi Roohnikan and Sahil Shah, in this upcoming webinar that will uncover key aspects to consider for CMC testing for protein-based therapeutics. Topics will include FDA expectations for NDA submissions, analytical challenges unique to mAB/ADC, techniques utilized for demonstrating product quality attributes, and guidance for a successful CMC testing program. Register today to save your seat and receive a complimentary recording! Link: https://bit.ly/4cc59hu #drugdevelopment #biologicstesting #biopharmatesting #SGSNorthAmerica
We're thrilled to share our comprehensive analysis of the impact of the new Clinical Trials Regulation (CTR) on clinical trial submission timelines in Belgium, including an in-depth analysis of our own Clinical Pharmacology Unit stats. This report delves into the factors cementing Belgium's reputation as a premier hub for early-phase trials. Swipe to preview a few pages! Get your full copy right here 👉 https://lnkd.in/ewupSyfC #healthscience
We are halfway through 2024 already! Let's take a look at some of our key successes for the year so far... 🚀 Proudly launched our new Good Clinical Practice (GCP) compliance audits. 🔬 Expanding our Birsfelden, Switzerland laboratory to include stability studies, making it a one-stop-shop for GMP/non-GMP biopharmaceutical analytics. 🏆 We proudly accepted CRO Leadership awards across all 5 categories, thanks to the recognition from our customers! 🙌 One year after Clinical Trial Regulation (CTR) implementation, Belgium has successfully maintained its competitive edge in early-phase clinical trial timelines. 📜 Our laboratory in Fairfield, NJ, USA, has achieved the prestigious ISO/IEC 17025:2017 certification, this underscores our dedication to quality and excellence in laboratory services. 🌎 Our experts attended over 100 events across the globe! ⭐ and more... #healthscience
Our E&L expert, Dujuan Lu, will be part of a Roundtable Discussion on Trends, Best Practices, and Analytical Challenges in Chemical Characterization of Medical Devices. This webcast is sponsored by Agilent and presented by LCGC International. It is on Thursday June 27 at 8:00 AM PDT / 11:00 AM EDT / 4.00 PM BST and 5:00 PM CEST. Don't miss out, sign up here 👉https://lnkd.in/eU6hpkEc More information below 👇 #drugdevelopment
🚀 Central laboratories rise to the occasion in optimizing oncology clinical trials. Amidst the complexity of diverse sample types, multiple trials, and limited time frames, a beacon of support emerges – the central laboratory. Here's how they support study sites: 🔹 Navigating logistics 🔹 Ensuring precision with study-specific kits 🔹 Simplifying with user-centric kit designs 🔹 Providing comprehensive lab manuals 🔹 Empowering teams through training And more... Check out the full article to learn more 👉 https://lnkd.in/g-hr3R_9 #healthscience #oncology #cancerresearch